Retour
Fourchette du Jour
5,09 €
5,52 €
Fourchette 52 Semaines
1,29 €
7,18 €
Volume
2 160 682
Moyenne 50J / 200J
5,73 €
/
3,77 €
Clôture Précédente
5,00 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4,6 | 0,3 |
| P/B | 2,2 | 3,0 |
| ROE % | -50,8 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
16,00 €
+198.2%
BPA Prévisionnel
-1,05 €
CA Est.
2,36M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
1,02 €
1,02 € – 1,02 €
|
612,06M | 4 |
| FY2028 |
0,17 €
-0,62 € – 1,31 €
|
324,34M | 6 |
| FY2027 |
-0,79 €
-1,13 € – -0,50 €
|
55,92M | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-10 | -0,34 € | -0,37 € | -8,8% |
| 2025-08-14 | -0,36 € | -0,34 € | +5,6% |
| 2025-05-12 | -0,30 € | -0,37 € | -23,3% |
| 2025-03-03 | -0,28 € | -0,33 € | -17,9% |
| 2024-11-14 | -0,26 € | -0,25 € | +3,8% |
| 2024-08-12 | -0,23 € | -0,23 € | 0,0% |
| 2024-05-13 | -0,32 € | -0,21 € | +34,4% |
| 2024-03-26 | -0,45 € | -0,36 € | +20,0% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,10 — conservative balance sheet
Negative free cash flow of -118,02M
PEG of 0,12 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-50,84%
ROIC-35,88%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,10
Current Ratio10,37
Interest Coverage0,00
Valorisation
P/E Ratio
-4,64
Forward P/EN/A
P/B Ratio2,19
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -138,20M |
| ROE | -50,84% | ROA | -39,48% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -118,02M |
| ROIC | -35,88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,10 | Current Ratio | 10,37 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4,64 | Forward P/E | N/A |
| P/B Ratio | 2,19 | P/S Ratio | N/A |
| PEG Ratio | 0,12 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 203,69 | Fwd Earnings Yield | N/A |
| FCF Yield | -18,39% | ||
| Market Cap | 641,63M | Enterprise Value | 621,10M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -138,20M | -134,24M | -141,95M | -130,32M | -63,41M |
| EPS (Diluted) | -1,01 | -1,77 | -2,60 | -3,34 | -3,70 |
| Gross Profit | -3,45M | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -154,07M | -143,72M | -145,60M | -130,71M | -63,47M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 350,07M | 297,67M | 285,10M | 287,04M | 355,95M |
| Total Liabilities | 56,97M | 47,12M | 53,90M | 55,13M | 11,67M |
| Shareholders' Equity | 293,11M | 250,56M | 231,19M | 231,91M | 344,28M |
| Total Debt | 28,97M | 31,36M | 32,86M | 34,59M | 0,0 |
| Cash & Equivalents | 49,50M | 225,11M | 140,02M | 74,84M | 268,57M |
| Current Assets | 316,46M | 263,86M | 248,10M | 247,69M | 354,01M |
| Current Liabilities | 30,51M | 17,93M | 22,36M | 21,74M | 10,62M |